Treatment of Plasmodium falciparum in a 1.2-year-old Child
For a 1.2-year-old child diagnosed with Plasmodium falciparum malaria, the recommended first-line treatment is artemisinin-based combination therapy (ACT), specifically artemether-lumefantrine or dihydroartemisinin-piperaquine, with appropriate weight-based dosing. 1
Assessment of Severity
First, determine if the child has uncomplicated or severe malaria:
Signs of Severe Malaria (requiring hospitalization):
- Severe anemia
- Hemoglobinuria, oliguria, or anuria
- Hypotension and respiratory distress
- Jaundice
- Hemorrhagic diatheses
- Cerebral malaria (drowsiness, mental confusion, coma, seizures)
- Hypoglycemia
- Parasitemia >5% in non-immune patients 1
Treatment Algorithm
For Uncomplicated P. falciparum Malaria:
First-line therapy (oral):
- Artemether-lumefantrine (20 mg + 120 mg): For a child weighing 5-<15 kg, give 1 tablet at 0,8,24,36,48, and 60 hours (total of 6 doses over 3 days)
- OR Dihydroartemisinin-piperaquine: For a child weighing 5-10 kg, give 1/8 tablet (40 mg/5 mg) once daily for 3 days 1
Administration considerations:
If vomiting occurs:
- If within 30 minutes of dose: repeat the full dose
- If 30-60 minutes after dose: give half the dose
- If vomiting persists: consider parenteral therapy 1
For Severe P. falciparum Malaria:
Immediate hospitalization with parenteral therapy:
- Intravenous quinine: Loading dose 20 mg/kg over 4 hours, followed by 10 mg/kg every 8 hours 1
- Monitor for hypoglycemia, which is a common complication of both severe malaria and quinine treatment
Supportive care:
- Maintain hydration with IV fluids (5% dextrose with 1/2 normal saline at 10 mL/kg over 3 hours)
- Monitor blood glucose regularly
- Control fever with paracetamol
- Treat seizures according to pediatric protocols 1
Blood transfusion: Consider if hemoglobin <4 g/dL or <6 g/dL with signs of respiratory distress 1
Switch to oral therapy: Once the child can tolerate oral medication and shows clinical improvement, complete treatment with a full course of oral ACT 1
Monitoring
- Check parasitemia daily until negative
- Monitor hemoglobin, glucose, and renal function
- Assess for clinical improvement (fever resolution, improved consciousness)
- Follow up after completion of therapy to ensure cure 1
Important Considerations
- ACTs are the preferred treatment due to their rapid parasite clearance and good safety profile 1
- Avoid mefloquine in children under 3 months or weighing less than 5 kg due to limited data 2
- Do not use steroids for cerebral malaria as they can worsen outcomes 1
- If no improvement within 48-72 hours of starting treatment, consider alternative therapy or drug resistance 2
Prompt and appropriate treatment is crucial as P. falciparum can rapidly progress to severe disease in young children, with high morbidity and mortality if not properly managed.